Further studies using a Mendelian randomization approach (which uses genetic single nucleotide polymorphisms linked to specific biomarker changes as instruments to help interrogate causality) could be helpful in examining whether there is a direct causal association between copeptin and insulin resistance and copeptin and type 2 diabetes. This evidence concerns the gene AVP and type 2 diabetes mellitus.